Campbell Associates (Lethbridge) Limited

University of Cincinnati Leads Multicenter Trial Testing Extended Tranexamic Acid for ACL Surgery Recovery

- The University of Cincinnati is leading a multicenter clinical trial to test extended oral tranexamic acid (TXA) dosing for seven days after ACL reconstruction surgery to improve recovery outcomes. - The randomized controlled trial will enroll 100 participants aged 14-22 across six medical centers, comparing extended TXA treatment to placebo for post-surgical recovery. - Extended TXA dosing has shown improved results in joint replacement procedures and may reduce pain, swelling, and promote earlier movement in ACL patients. - Researchers expect the treatment could prevent arthrogenic muscle inhibition and allow athletes to return to sports sooner than the typical 9-12 month recovery period.